ElexoPharm Appoints Dr. Chris J. van Koppen as Head of Research

20-Apr-2012 - Germany

Efficient inline analysis for liquids and solids

Revolutionize your production: real-time Raman analysis for maximum efficiency

Freeze Drying with the Refrigerant of the Future

ElexoPharm GmbH announces the appointment of Dr. Chris J. van Koppen as Head of Research. He will lead the preclinical drug discovery projects of ElexoPharm and will build further alliances with larger pharmaceutical companies.

Dr. van Koppen holds a Ph.D. in Pharmacology and brings extensive industry experience in drug discovery. Before joining ElexoPharm in January 2012, he served as Leader of four lead optimization projects at Merck Sharp & Dohme, The Netherlands. He was responsible for delivery of candidate drugs for preclinical development in endocrinological diseases. Dr. van Koppen was also strongly involved in assay development, HTS, lead finding and proof-of-concept projects. Before working at MSD, Dr. van Koppen was independent group leader at the Universitätsklinikum Essen and received his Habilitation in Pharmacology and Toxicology. He has published almost 70 peer-reviewed research papers, including publications in high IF journals (J Biol Chem, Endocrinology, J Clin Endocrinol Metab, PNAS, Mol Pharmacol, Br J Pharmacol, Thorax, Pharmacol Ther, and EMBO Journal).

https://www.bionity.com/en/news/137543/elexopharm-appoints-dr-chris-j-van-koppen-as-head-of-research.html